The new 12-month forecast for 180 Life Sciences Corp($ATNF) is out now

Market Data

180 Life Sciences Corp(ATNF) is a stock of interest due to the large impact the company has on the market. Here at Wall Street Facts we only cover the best stocks so make sure you check out our other articles. Today we will be diving deep into all of the essential information you need to know about ATNF. We will be studying the movement so you can make the best decision as an investor. The stock has moved downwards today by 2.61%. The high for today is 7.88 and today’s low is 7.50. This information is critical in deciding whether this investment is risky or not. We can see the stock is trending downwards, which means the volume of people selling this stock is greater than people buying it.

Company Description

180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded in 2016 and is headquartered in Menlo Park, CA.

Stock Forecast

As an investor, you can get an idea of where the stock is trending by the forecast. In this case, the high forecast for 180 Life Sciences Corp is $29.00 and the low forecast is $17.00. Overall, 180 Life Sciences Corp is in great shape going forward. They have a strong market cap of $188.81M and a very bright future ahead of them. Make sure to subscribe to our newsletter to never miss an update!

Leave a Reply

%d bloggers like this: